Death from thyroid cancer of follicular cell origin1

Slides:

Advertisements

Similar presentations

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Advertisements

Su K. Metcalfe, MD, MPH, Michael T

Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy Lina Wang, MD, Hao.

Volume 144, Issue 4, Pages (October 2013)

Volume 105, Issue 3, Pages (March 1994)

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Volume 13, Issue 12, Pages (December 2012)

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Mitral stenosis with pulmonary hypertension: We should operate early

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2 Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy

The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis Annemarie T. Fernandes, BA, Eric.

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure Jessamy A. Boyd, MD, Jessica L. Hubbs,

Perceived Complexity of Various Liver Resections: Results of a Survey of Experts with Development of a Complexity Score and Classification Major K. Lee,

Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic.

Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller Jung-Jyh Hung, MD, PhD, Yi-Chen Yeh, MD, Yu-Chung Wu,

Andrea S. Wolf, MD, MPH, Scott J

Volume 13, Issue 12, Pages (December 2012)

Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non–small cell lung cancer

Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer Jung-Jyh Hung, MD,

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Interstitial tumor-associated macrophages combined with tumor-derived colony- stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non–small.

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene.

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Changing Surgical Trends in Young Patients with Early Stage Breast Cancer, 2003 to 2010: A Report from the National Cancer Data Base Catherine E. Pesce,

Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer Jianlin Xu, MD, Haitang Yang, MD, Xiaolong Fu, MD, Bo Jin,

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Deceased-Donor Split-Liver Transplantation in Adult Recipients: Is the Learning Curve Over? Ryan P. Cauley, MD, MPH, Khashayar Vakili, MD, FACS, Nora.

Thoracoscopic Lobectomy Produces Long-Term Survival Similar to That with Open Lobectomy in Cases of Non–Small Cell Lung Carcinoma: A Propensity-Matched.

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response.

Characteristics of Malignant Pleural Mesothelioma in Women

Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat Study Marcello Carlo Ambrogi,

Frequency and Prognostic Significance of Preoperatively Detected Enlarged Regional Lymph Nodes in Patients with Pathological Stage I Non-small Cell Lung.

It’s All in the “Swerve of the Curve”

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

Pulmonary Resection for Metastases from Colorectal Cancer

E.Stanley Crawford, M.D., Ralph W. DeNatale, M.D.

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer Alessandro Brunelli, MD, Michele.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Surgical outcomes after cardiac surgery in liver transplant recipients

Blake Cady, MD, Thomas Miner, MD, Abraham Morgentaler, MD

Impact of Immunotherapy after Resection of Pancreatic Cancer

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for.

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Death from thyroid cancer of follicular cell origin1 Hurng-Sheng Wu, MD, Michael T Young, Philip H.G Ituarte, Phd, mph, Alessandra D’Avanzo, MD, Quan-Yang Duh, md, Francis S Greenspan, MD, Keh Chuan Loh, MD, Orlo H Clark, md Journal of the American College of Surgeons Volume 191, Issue 6, Pages 600-606 (December 2000) DOI: 10.1016/S1072-7515(00)00731-6

Figure 1 Kaplan-Meier cumulative probability of survival by age in 102 patients with differentiated thyroid cancer of follicular cell origin. Journal of the American College of Surgeons 2000 191, 600-606DOI: (10.1016/S1072-7515(00)00731-6)

Figure 2 Kaplan-Meier cumulative probability of survival by diagnosis. Journal of the American College of Surgeons 2000 191, 600-606DOI: (10.1016/S1072-7515(00)00731-6)

Figure 3 Kaplan-Meier cumulative probability of survival by TNM stage. Journal of the American College of Surgeons 2000 191, 600-606DOI: (10.1016/S1072-7515(00)00731-6)

Figure 4 Kaplan-Meier cumulative probability of survival by MACIS score. MACIS, metastases, age, completeness of resection, invasion, size. Journal of the American College of Surgeons 2000 191, 600-606DOI: (10.1016/S1072-7515(00)00731-6)

Figure 5 Kaplan-Meier cumulative probability of survival for persistent (6 months) versus recurrent disease. Journal of the American College of Surgeons 2000 191, 600-606DOI: (10.1016/S1072-7515(00)00731-6)

Figure 6 Kaplan-Meier cumulative probability of survival for recurrent thyroid cancer by local, regional, and distant metastases. Journal of the American College of Surgeons 2000 191, 600-606DOI: (10.1016/S1072-7515(00)00731-6)